Ygion Biomedical

YGION Biomedical is an Austrian biotechnology company, dedicated to make individualized cancer immunotherapy a reality. By applying groundbreaking, innovative technologies, we strive to provide better and more effective treatments to cancer patients. Our approach encompasses a targeted activation of the patient’s immune system, promising to elicit a fast, strong, and long-lasting specific immune response with an excellent safety profile. We believe that directing the patient’s immune system specifically against the tumor will provide an opportunity for long-term protection against tumor relapse and metastasis and thus will contribute to an improved success for the treatment of cancer.